AEON Biopharma, Inc. – NASDAQ:AEON

AEON Biopharma stock price today

$0.748
+0.15
+26.76%
Financial Health
0
1
2
3
4
5
6
7
8
9

AEON Biopharma stock price monthly change

-57.86%
month

AEON Biopharma stock price quarterly change

-57.86%
quarter

AEON Biopharma stock price yearly change

-91.69%
year

AEON Biopharma key metrics

Market Cap
25.29M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
N/A
Revenue
N/A
EBITDA
59.29M
Income
-180.65M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

AEON Biopharma stock price history

AEON Biopharma stock forecast

AEON Biopharma financial statements

AEON Biopharma, Inc. (NASDAQ:AEON): Profit margin
Sep 2022 0 -10.43M
Dec 2022 0 -34.56M
Mar 2023 0 -17.63M
Mar 2024 0 -118.01M
AEON Biopharma, Inc. (NASDAQ:AEON): Earnings per share (EPS)
2024-03-29 -0.4 -0.71
2024-05-14 -0.31 -0.28
AEON Biopharma, Inc. (NASDAQ:AEON): Debt to assets
Dec 2021 6436000 230.26M 3577.69%
Dec 2022 10778000 281.19M 2608.93%
Sep 2023 17619000 139.35M 790.96%
Mar 2024 3032000 201.41M 6642.91%
AEON Biopharma, Inc. (NASDAQ:AEON): Cash Flow
Mar 2024 -8.6M 0 5M

AEON Biopharma alternative data

AEON Biopharma, Inc. (NASDAQ:AEON): Employee count
Aug 2023 6
Sep 2023 6
Oct 2023 9
Nov 2023 9
Dec 2023 8
Jan 2024 8
Feb 2024 8
Mar 2024 8
Apr 2024 8
May 2024 10
Jun 2024 10
Jul 2024 10

AEON Biopharma other data

AEON Biopharma, Inc. (NASDAQ:AEON): Insider trades (number of shares)
Period Buy Sel
Aug 2023 0 7380394
Transaction Date Insider Security Shares Price per share Total value Source
Sale
STRATHSPEY CROWN HOLDINGS GROUP, LLC 10 percent owner
Class A Common Stock 7,380,394 $10 $73,803,940
Sale
GLAZER CAPITAL, LLC 10 percent owner
Units 73,226 $10.1 $739,583
Sale
GLAZER CAPITAL, LLC 10 percent owner
Units 650 $10.2 $6,630
Sale
GLAZER CAPITAL, LLC 10 percent owner
Units 100,000 $10.15 $1,015,000
Sale
GLAZER CAPITAL, LLC 10 percent owner
Units 11,033 $10.2 $112,537
Sale
GLAZER CAPITAL, LLC 10 percent owner
Units 3,500 $10.2 $35,700
Sale
GLAZER CAPITAL, LLC 10 percent owner
Units 62,356 $10.35 $645,385
Sale
GLAZER CAPITAL, LLC 10 percent owner
Units 10,000 $10.65 $106,500
Sale
GLAZER CAPITAL, LLC 10 percent owner
Units 10,000 $10.5 $105,000
Wednesday, 13 November 2024
globenewswire.com
Wednesday, 21 August 2024
zacks.com
Monday, 19 August 2024
globenewswire.com
Monday, 12 August 2024
globenewswire.com
Wednesday, 29 May 2024
zacks.com
globenewswire.com
Tuesday, 14 May 2024
globenewswire.com
Thursday, 9 May 2024
zacks.com
globenewswire.com
Friday, 3 May 2024
globenewswire.com
Friday, 19 April 2024
Zacks Investment Research
Monday, 31 July 2023
GuruFocus
  • What's the price of AEON Biopharma stock today?

    One share of AEON Biopharma stock can currently be purchased for approximately $0.75.

  • When is AEON Biopharma's next earnings date?

    Unfortunately, AEON Biopharma's (AEON) next earnings date is currently unknown.

  • Does AEON Biopharma pay dividends?

    No, AEON Biopharma does not pay dividends.

  • How much money does AEON Biopharma make?

    AEON Biopharma has a market capitalization of 25.29M. AEON Biopharma made a loss 52.56M US dollars in net income (profit) last year or -$0.28 on an earnings per share basis.

  • What is AEON Biopharma's stock symbol?

    AEON Biopharma, Inc. is traded on the NASDAQ under the ticker symbol "AEON".

  • What is AEON Biopharma's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of AEON Biopharma?

    Shares of AEON Biopharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does AEON Biopharma have?

    As Jul 2024, AEON Biopharma employs 10 workers, which is 25% more then previous quarter.

  • When AEON Biopharma went public?

    AEON Biopharma, Inc. is publicly traded company for more then 2 years since IPO on 24 Jul 2023.

  • What is AEON Biopharma's official website?

    The official website for AEON Biopharma is aeonbiopharma.com.

  • Where are AEON Biopharma's headquarters?

    AEON Biopharma is headquartered at 4040 Macarthur Boulevard, Newport Beach, CA.

  • How can i contact AEON Biopharma?

    AEON Biopharma's mailing address is 4040 Macarthur Boulevard, Newport Beach, CA and company can be reached via phone at +94 93546499.

AEON Biopharma company profile:

AEON Biopharma, Inc.

aeonbiopharma.com
Exchange:

NASDAQ

Full time employees:

5

Industry:

Biotechnology

Sector:

Healthcare

AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.

4040 Macarthur Boulevard
Newport Beach, CA 92614

CIK: 0001622667
ISIN: US00791X1000
CUSIP: 00775E102